High materiality7/10
H.C. Wainwright Reiterates Buy Rating on AnaptysBio (ANAB)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates a Buy rating on AnaptysBio (ANAB) with a target of $95; current price around $54.92.
- H.C. Wainwright reiterates Buy on ANAB; target $95; price $54.92.
Key facts
- 01
Target: $95
- 02
Posted price: $54.92
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Joseph Pantginis
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.